EpiCypher, Inc

A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers world-wide. Our technologies and products are making studies possible that were not imaginable just a few years ago. Our renowned chromatin researchers possess expertise and unique insight into chromatin biology and drug discovery that benefit our customers in ways other companies cannot. Epigenetics, the study of changes in heritable traits that occur independent of alterations in changes in the underlying DNA sequence, is an emerging and important area of biomedical research with broad impact on human...

Epigenetics,chromatin,histone,nucleosome,histone modification,histone methylation,histone acetylation,histone binding proteins,epigenomics,recombinant nucleosome,designer nucleosome,drug discovery,spike-in ,chip,chromatin immunoprecipitation,and high throughput assay development

Epicypher, inc operates in the Biotechnology research industry.

Epicypher, inc's revenue is 11m - 100m

Epicypher, inc has 51 - 200 employees.